{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:40:58Z","timestamp":1791726058497,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T00:00:00Z","timestamp":1592265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009053","name":"DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/S\/17\/1\/503071"],"award-info":[{"award-number":["IA\/S\/17\/1\/503071"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR14730\/BRB\/10\/874\/2010"],"award-info":[{"award-number":["BT\/PR14730\/BRB\/10\/874\/2010"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/005296"],"award-info":[{"award-number":["EMR\/2016\/005296"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anti-tuberculosis (TB) drugs, while being highly potent in vitro, require prolonged treatment to control\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    (\n                    <jats:italic>Mtb<\/jats:italic>\n                    ) infections in vivo. We report here that mesenchymal stem cells (MSCs) shelter\n                    <jats:italic>Mtb<\/jats:italic>\n                    to help tolerate anti-TB drugs. MSCs readily take up\n                    <jats:italic>Mtb<\/jats:italic>\n                    and allow unabated mycobacterial growth despite having a functional innate pathway of phagosome maturation. Unlike macrophage-resident ones, MSC-resident\n                    <jats:italic>Mtb<\/jats:italic>\n                    tolerates anti-TB drugs remarkably well, a phenomenon requiring proteins ABCC1, ABCG2 and vacuolar-type H\n                    <jats:sup>+<\/jats:sup>\n                    ATPases. Additionally, the classic pro-inflammatory cytokines IFN\u03b3 and TNF\u03b1 aid mycobacterial growth within MSCs. Mechanistically, evading drugs and inflammatory cytokines by MSC-resident\n                    <jats:italic>Mtb<\/jats:italic>\n                    is dependent on elevated PGE2 signaling, which we verify in vivo analyzing sorted CD45\n                    <jats:sup>\u2212<\/jats:sup>\n                    Sca1\n                    <jats:sup>+<\/jats:sup>\n                    CD73\n                    <jats:sup>+<\/jats:sup>\n                    -MSCs from lungs of infected mice. Moreover, MSCs are observed in and around human tuberculosis granulomas, harboring\n                    <jats:italic>Mtb<\/jats:italic>\n                    bacilli. We therefore propose, targeting the unique immune-privileged niche, provided by MSCs to\n                    <jats:italic>Mtb<\/jats:italic>\n                    , can have a major impact on tuberculosis prevention and cure.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-16877-3","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T06:04:43Z","timestamp":1592287483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Mesenchymal stem cells offer a drug-tolerant and immune-privileged niche to Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"11","author":[{"given":"Neharika","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Kalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshyaveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vartika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-8573","authenticated-orcid":false,"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7578-2930","authenticated-orcid":false,"given":"Dhiraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"16877_CR1","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1126\/science.1184784","volume":"328","author":"DG Russell","year":"2010","unstructured":"Russell, D. G., Barry, C. E. 3rd & Flynn, J. L. Tuberculosis: what we don\u2019t know can, and does, hurt us. Science 328, 852\u2013856 (2010).","journal-title":"Science"},{"key":"16877_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.12688\/f1000research.13588.1","volume":"7","author":"G Voss","year":"2018","unstructured":"Voss, G. et al. Progress and challenges in TB vaccine development. F1000Research 7, 199\u2013199 (2018).","journal-title":"F1000Research"},{"key":"16877_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.meegid.2011.07.019","volume":"12","author":"EM Streicher","year":"2012","unstructured":"Streicher, E. M. et al. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infect., Genet. Evolution 12, 686\u2013694 (2012).","journal-title":"Infect., Genet. Evolution"},{"key":"16877_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3389\/fimmu.2012.00411","volume":"3","author":"S Ehlers","year":"2013","unstructured":"Ehlers, S. & Schaible, U. E. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 3, 411\u2013411 (2013).","journal-title":"Front. Immunol."},{"key":"16877_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrmicro1065","volume":"3","author":"HI Boshoff","year":"2005","unstructured":"Boshoff, H. I. & Barry, C. E. 3rd Tuberculosis\u2014metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3, 70\u201380 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"16877_CR6","doi-asserted-by":"publisher","first-page":"E4256","DOI":"10.1073\/pnas.1316894110","volume":"110","author":"A Cunningham-Bussel","year":"2013","unstructured":"Cunningham-Bussel, A., Zhang, T. & Nathan, C. F. Nitrite produced by Mycobacterium tuberculosis in human macrophages in physiologic oxygen impacts bacterial ATP consumption and gene expression. Proc. Natl Acad. Sci. USA 110, E4256\u2013E4265 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16877_CR7","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/IAI.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne, L. G. & Hayes, L. G. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64, 2062\u20132069 (1996).","journal-title":"Infect. Immun."},{"key":"16877_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4110\/in.2009.9.2.46","volume":"9","author":"C-S Yang","year":"2009","unstructured":"Yang, C.-S., Yuk, J.-M. & Jo, E.-K. The role of nitric oxide in mycobacterial infections. Immune Netw. 9, 46\u201352 (2009).","journal-title":"Immune Netw."},{"key":"16877_CR9","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1128\/JB.00935-15","volume":"198","author":"K Flentie","year":"2016","unstructured":"Flentie, K., Garner, A. L. & Stallings, C. L. Mycobacterium tuberculosis transcription machinery: ready to respond to host attacks. J. Bacteriol. 198, 1360\u20131373 (2016).","journal-title":"J. Bacteriol."},{"key":"16877_CR10","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1074\/jbc.M115.684597","volume":"291","author":"M Mehta","year":"2016","unstructured":"Mehta, M., Rajmani, R. S. & Singh, A. Mycobacterium tuberculosis WhiB3 responds to vacuolar pH-induced changes in mycothiol redox potential to modulate phagosomal maturation and virulence. J. Biol. Chem. 291, 2888\u20132903 (2016).","journal-title":"J. Biol. Chem."},{"key":"16877_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.freeradbiomed.2018.11.032","volume":"131","author":"M Mehta","year":"2018","unstructured":"Mehta, M. & Singh, A. Mycobacterium tuberculosis WhiB3 maintains redox homeostasis and survival in response to reactive oxygen and nitrogen species. Free Radic. Biol. Med 131, 50\u201358 (2018).","journal-title":"Free Radic. Biol. Med"},{"key":"16877_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev.micro.57.030502.091033","volume":"57","author":"CL Cosma","year":"2003","unstructured":"Cosma, C. L., Sherman, D. R. & Ramakrishnan, L. The secret lives of the pathogenic mycobacteria. Annu Rev. Microbiol 57, 641\u2013676 (2003).","journal-title":"Annu Rev. Microbiol"},{"key":"16877_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00281-013-0388-2","volume":"35","author":"E Guirado","year":"2013","unstructured":"Guirado, E., Schlesinger, L. S. & Kaplan, G. Macrophages in tuberculosis: friend or foe. Semin. Immunopathol. 35, 563\u2013583 (2013).","journal-title":"Semin. Immunopathol."},{"key":"16877_CR14","doi-asserted-by":"publisher","first-page":"e1006676","DOI":"10.1371\/journal.ppat.1006676","volume":"13","author":"M Beigier-Bompadre","year":"2017","unstructured":"Beigier-Bompadre, M. et al. Mycobacterium tuberculosis infection modulates adipose tissue biology. PLOS Pathog. 13, e1006676 (2017).","journal-title":"PLOS Pathog."},{"key":"16877_CR15","doi-asserted-by":"publisher","first-page":"8619307","DOI":"10.1155\/2017\/8619307","volume":"2017","author":"IV Lyadova","year":"2017","unstructured":"Lyadova, I. V. Neutrophils in tuberculosis: heterogeneity shapes the way? Mediators Inflamm. 2017, 8619307 (2017).","journal-title":"Mediators Inflamm."},{"key":"16877_CR16","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ni.1781","volume":"10","author":"DG Russell","year":"2009","unstructured":"Russell, D. G., Cardona, P.-J., Kim, M.-J., Allain, S. & Altare, F. Foamy macrophages and the progression of the human TB granuloma. Nat. Immunol. 10, 943\u2013948 (2009).","journal-title":"Nat. Immunol."},{"key":"16877_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000439275","volume":"8","author":"JM Scordo","year":"2016","unstructured":"Scordo, J. M., Knoell, D. L. & Torrelles, J. B. Alveolar epithelial cells in Mycobacterium tuberculosis infection: active players or innocent bystanders? J. innate Immun. 8, 3\u201314 (2016).","journal-title":"J. innate Immun."},{"key":"16877_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15290-z","volume":"7","author":"A Khan","year":"2017","unstructured":"Khan, A. et al. Mesenchymal stem cells internalize Mycobacterium tuberculosis through scavenger receptors and restrict bacterial growth through autophagy. Sci. Rep. 7, 15010 (2017).","journal-title":"Sci. Rep."},{"key":"16877_CR19","doi-asserted-by":"publisher","first-page":"21653","DOI":"10.1073\/pnas.1007967107","volume":"107","author":"S Raghuvanshi","year":"2010","unstructured":"Raghuvanshi, S., Sharma, P., Singh, S., Van Kaer, L. & Das, G. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc. Natl Acad. Sci. USA 107, 21653\u201321658 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16877_CR20","first-page":"170ra113","volume":"5","author":"B Das","year":"2013","unstructured":"Das, B. et al. CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci. Transl. Med. 5, 170ra113\u2013170ra113 (2013).","journal-title":"Sci. Transl. Med."},{"key":"16877_CR21","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1128\/AAC.06288-11","volume":"56","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y., Yew, W. W. & Barer, M. R. Targeting persisters for tuberculosis control. Antimicrobial agents Chemother. 56, 2223\u20132230 (2012).","journal-title":"Antimicrobial agents Chemother."},{"key":"16877_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tube.2003.08.003","volume":"84","author":"JE Gomez","year":"2004","unstructured":"Gomez, J. E. & McKinney, J. D. M. Tuberculosis persistence, latency, and drug tolerance. Tuberculosis 84, 29\u201344 (2004).","journal-title":"Tuberculosis"},{"key":"16877_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.1229858","volume":"339","author":"Y Wakamoto","year":"2013","unstructured":"Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science 339, 91\u201395 (2013).","journal-title":"Science"},{"key":"16877_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","volume":"13","author":"ME Bernardo","year":"2013","unstructured":"Bernardo, M. E. & Fibbe, W. E. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13, 392\u2013402 (2013).","journal-title":"Cell Stem Cell"},{"key":"16877_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-pathol-011110-130230","volume":"6","author":"NG Singer","year":"2011","unstructured":"Singer, N. G. & Caplan, A. I. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev. Pathol. 6, 457\u2013478 (2011).","journal-title":"Annu Rev. Pathol."},{"key":"16877_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jocit.2014.12.001","volume":"2","author":"Q Zhao","year":"2016","unstructured":"Zhao, Q., Ren, H. & Han, Z. Mesenchymal stem cells: immunomodulatory capability and clinical potential in immune diseases. J. Cell. Immunother. 2, 3\u201320 (2016).","journal-title":"J. Cell. Immunother."},{"key":"16877_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep16320","volume":"5","author":"P Chandra","year":"2015","unstructured":"Chandra, P. et al. Mycobacterium tuberculosis inhibits RAB7 recruitment to selectively modulate autophagy flux in macrophages. Sci. Rep. 5, 16320 https:\/\/www.nature.com\/articles\/srep16320 (2015).","journal-title":"Sci. Rep."},{"key":"16877_CR28","doi-asserted-by":"publisher","first-page":"40307","DOI":"10.1074\/jbc.M111.266239","volume":"286","author":"AF Karim","year":"2011","unstructured":"Karim, A. F. et al. Express path analysis identifies a tyrosine kinase Src-centric network regulating divergent host responses to Mycobacterium tuberculosis infection. J. Biol. Chem. 286, 40307\u201340319 (2011).","journal-title":"J. Biol. Chem."},{"key":"16877_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cell.2010.02.012","volume":"140","author":"D Kumar","year":"2010","unstructured":"Kumar, D. et al. Genome-wide analysis of the host intracellular network that regulates survival of Mycobacterium tuberculosis. Cell 140, 731\u2013743 (2010).","journal-title":"Cell"},{"key":"16877_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48\u201358 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"16877_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrd1984","volume":"5","author":"G Szakacs","year":"2006","unstructured":"Szakacs, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C. & Gottesman, M. M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5, 219\u2013234 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"16877_CR32","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1073\/pnas.91.19.8822","volume":"91","author":"GJ Zaman","year":"1994","unstructured":"Zaman, G. J. et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl Acad. Sci. USA 91, 8822\u20138826 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16877_CR33","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/ijc.23677","volume":"123","author":"C Lemos","year":"2008","unstructured":"Lemos, C. et al. Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco\u20102 cells. Int. J. Cancer 123, 1712\u20131720 (2008).","journal-title":"Int. J. Cancer"},{"key":"16877_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/1574-6968.12412","volume":"353","author":"W Ahmed","year":"2014","unstructured":"Ahmed, W., Menon, S., Godbole, A. A., Karthik, P. V. & Nagaraja, V. Conditional silencing of topoisomerase I gene of Mycobacterium tuberculosis validates its essentiality for cell survival. FEMS Microbiol Lett. 353, 116\u2013123 (2014).","journal-title":"FEMS Microbiol Lett."},{"key":"16877_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/jac\/dkr449","volume":"67","author":"S Chopra","year":"2012","unstructured":"Chopra, S. et al. Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 67, 415\u2013421 (2012).","journal-title":"J. Antimicrob. Chemother."},{"key":"16877_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"D Klionsky","year":"2016","unstructured":"Klionsky, D. et al. Guidelines for the use and interpretation of assays for monitoring autophagy 3rd edn. Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"16877_CR37","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.20151248","volume":"213","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. J. Exp. Med. 213, 809\u2013825 (2016).","journal-title":"J. Exp. Med."},{"key":"16877_CR38","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1128\/IAI.01872-06","volume":"75","author":"JA MacGurn","year":"2007","unstructured":"MacGurn, J. A. & Cox, J. S. A genetic screen for <em>Mycobacterium tuberculosis<\/em> mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect. Immun. 75, 2668 (2007).","journal-title":"Infect. Immun."},{"key":"16877_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2217\/17460913.3.5.517","volume":"3","author":"V Deretic","year":"2008","unstructured":"Deretic, V. Autophagy, an immunologic magic bullet: Mycobacterium tuberculosis phagosome maturation block and how to bypass it. Future Microbiol. 3, 517\u2013524 (2008).","journal-title":"Future Microbiol."},{"key":"16877_CR40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s12015-016-9690-4","volume":"12","author":"FV Sbrana","year":"2016","unstructured":"Sbrana, F. V. et al. The role of autophagy in the maintenance of stemness and differentiation of mesenchymal stem cells. Stem Cell Rev. Rep. 12, 621\u2013633 (2016).","journal-title":"Stem Cell Rev. Rep."},{"key":"16877_CR41","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1080\/15548627.2016.1139263","volume":"12","author":"P Chandra","year":"2016","unstructured":"Chandra, P. & Kumar, D. Selective autophagy gets more selective: uncoupling of autophagy flux and xenophagy flux in Mycobacterium tuberculosis-infected macrophages. Autophagy 12, 608\u2013609 (2016).","journal-title":"Autophagy"},{"key":"16877_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biocel.2015.07.010","volume":"66","author":"SK Matta","year":"2015","unstructured":"Matta, S. K. & Kumar, D. AKT mediated glycolytic shift regulates autophagy in classically activated macrophages. Int. J. Biochem. Cell Biol. 66, 121\u2013133 (2015).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"16877_CR43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/scrt2","volume":"1","author":"S Ghannam","year":"2010","unstructured":"Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C. & Noel, D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem cell Res. Ther. 1, 2 (2010).","journal-title":"Stem cell Res. Ther."},{"key":"16877_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42\u201349 (2009).","journal-title":"Nat. Med."},{"key":"16877_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cellimm.2010.06.006","volume":"264","author":"M Najar","year":"2010","unstructured":"Najar, M. et al. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: combined comparison of adipose tissue, Wharton\u2019s Jelly and bone marrow sources. Cell. Immunol. 264, 171\u2013179 (2010).","journal-title":"Cell. Immunol."},{"key":"16877_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione, A. et al. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367\u2013372 (2006).","journal-title":"Blood"},{"key":"16877_CR47","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling, W. et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res. 74, 1576\u20131587 (2014).","journal-title":"Cancer Res."},{"key":"16877_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13287-017-0744-6","volume":"8","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. Stem Cell Res. Ther. 8, 292 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"16877_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/154732804323099190","volume":"13","author":"W Zhang","year":"2004","unstructured":"Zhang, W. et al. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 13, 263\u2013271 (2004).","journal-title":"Stem Cells Dev."},{"key":"16877_CR50","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","volume":"55","author":"AM Kalle","year":"2011","unstructured":"Kalle, A. M. & Rizvi, A. Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor. Antimicrob. Agents Chemother. 55, 439\u2013442 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"16877_CR51","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1073\/pnas.1033060100","volume":"100","author":"G Reid","year":"2003","unstructured":"Reid, G. et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl Acad. Sci. USA 100, 9244\u20139249 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16877_CR52","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20172020","volume":"215","author":"L Huang","year":"2018","unstructured":"Huang, L., Nazarova, E. V., Tan, S., Liu, Y. & Russell, D. G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med. 215, 1135\u20131152 (2018).","journal-title":"J. Exp. Med."},{"key":"16877_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4103\/0971-3026.184417","volume":"26","author":"R Sharma","year":"2016","unstructured":"Sharma, R., Madhusudhan, K. S. & Ahuja, V. Intestinal tuberculosis versus crohn\u2019s disease: clinical and radiological recommendations. Indian J. Radiol. Imaging 26, 161\u2013172 (2016).","journal-title":"Indian J. Radiol. Imaging"},{"key":"16877_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","volume":"145","author":"KN Adams","year":"2011","unstructured":"Adams, K. N. et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145, 39\u201353 (2011).","journal-title":"Cell"},{"key":"16877_CR55","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.ajpath.2014.08.024","volume":"184","author":"G Beamer","year":"2014","unstructured":"Beamer, G., Major, S., Das, B. & Campos-Neto, A. Bone marrow mesenchymal stem cells provide an antibiotic-protective niche for persistent viable Mycobacterium tuberculosis that survive antibiotic treatment. Am. J. Pathol. 184, 3170\u20133175 (2014).","journal-title":"Am. J. Pathol."},{"key":"16877_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/14622416.9.1.105","volume":"9","author":"FJ Sharom","year":"2007","unstructured":"Sharom, F. J. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9, 105\u2013127 (2007).","journal-title":"Pharmacogenomics"},{"key":"16877_CR57","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1158\/1535-7163.MCT-10-0108","volume":"9","author":"A Singh","year":"2010","unstructured":"Singh, A. et al. Expression of ABCG2 (BCRP), a marker of stem cells, is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype. Mol. Cancer Ther. 9, 2365\u20132376 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"16877_CR58","doi-asserted-by":"publisher","unstructured":"Mishra, R. et al. Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis. Sci Transl Med 11, https:\/\/doi.org\/10.1126\/scitranslmed.aaw6635 (2019).","DOI":"10.1126\/scitranslmed.aaw6635"},{"key":"16877_CR59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.tips.2006.06.008","volume":"27","author":"SPC Cole","year":"2006","unstructured":"Cole, S. P. C. & Deeley, R. G. Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol. Sci. 27, 438\u2013446 (2006).","journal-title":"Trends Pharmacol. Sci."},{"key":"16877_CR60","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neo.2015.01.004","volume":"17","author":"S-C Liang","year":"2015","unstructured":"Liang, S.-C. et al. ABCG2 localizes to the nucleus and modulates CDH1 expression in lung cancer cells()()(). Neoplasia 17, 265\u2013278 (2015).","journal-title":"Neoplasia"},{"key":"16877_CR61","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbagen.2014.05.022","volume":"1850","author":"F Seyffer","year":"2015","unstructured":"Seyffer, F. & Tampe, R. ABC transporters in adaptive immunity. Biochim. et. Biophys. Acta 1850, 449\u2013460 (2015).","journal-title":"Biochim. et. Biophys. Acta"},{"key":"16877_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06646-8","volume":"9","author":"S Chandra","year":"2018","unstructured":"Chandra, S. et al. Mrp1 is involved in lipid presentation and iNKT cell activation by Streptococcus pneumoniae. Nat. Commun. 9, 4279 (2018).","journal-title":"Nat. Commun."},{"key":"16877_CR63","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00424-006-0116-z","volume":"453","author":"J Bryan","year":"2007","unstructured":"Bryan, J. et al. ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflug. Arch. 453, 703\u2013718 (2007).","journal-title":"Pflug. Arch."},{"key":"16877_CR64","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tube.2003.12.010","volume":"84","author":"T Hampshire","year":"2004","unstructured":"Hampshire, T. et al. Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis 84, 228\u2013238 (2004).","journal-title":"Tuberculosis"},{"key":"16877_CR65","doi-asserted-by":"publisher","unstructured":"Bartek, I. L. et al. Antibiotic bactericidal activity is countered by maintaining ph homeostasis in Mycobacterium smegmatis. mSphere 1, https:\/\/doi.org\/10.1128\/mSphere.00176-16 (2016).","DOI":"10.1128\/mSphere.00176-16"},{"key":"16877_CR66","doi-asserted-by":"publisher","first-page":"10510","DOI":"10.1073\/pnas.1818009116","volume":"116","author":"K Flentie","year":"2019","unstructured":"Flentie, K. et al. Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 116, 10510\u201310517 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"16877_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12931-015-0316-1","volume":"17","author":"W Broekman","year":"2016","unstructured":"Broekman, W. et al. TNF-alpha and IL-1beta-activated human mesenchymal stromal cells increase airway epithelial wound healing in vitro via activation of the epidermal growth factor receptor. Respir. Res. 17, 3 (2016).","journal-title":"Respir. Res."},{"key":"16877_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","volume":"149","author":"JM Ryan","year":"2007","unstructured":"Ryan, J. M., Barry, F., Murphy, J. M. & Mahon, B. P. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin. Exp. Immunol. 149, 353\u2013363 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"16877_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2016.22","volume":"2","author":"SK Matta","year":"2016","unstructured":"Matta, S. K. & Kumar, D. Hypoxia and classical activation limits Mycobacterium tuberculosis survival by Akt-dependent glycolytic shift in macrophages. Cell Death Discov. 2, 16022, http:\/\/www.nature.com\/cddiscovery (2016).","journal-title":"Cell Death Discov."},{"key":"16877_CR70","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tube.2018.08.013","volume":"113","author":"K Atmakuri","year":"2018","unstructured":"Atmakuri, K., Penn-Nicholson, A., Tanner, R. & Dockrell, H. M. Meeting report: 5th global forum on TB vaccines, 20\u201323 February 2018, New Delhi India. Tuberculosis 113, 55\u201364 (2018).","journal-title":"Tuberculosis"},{"key":"16877_CR71","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","volume":"181","author":"S Bertholet","year":"2008","unstructured":"Bertholet, S. et al. Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis. J. Immunol. (Baltim., Md.: 1950) 181, 7948\u20137957 (2008).","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"16877_CR72","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3389\/fimmu.2017.01262","volume":"8","author":"DA Lewinsohn","year":"2017","unstructured":"Lewinsohn, D. A., Lewinsohn, D. M. & Scriba, T. J. Polyfunctional CD4(+) T cells as targets for Tuberculosis Vaccination. Front. Immunol. 8, 1262\u20131262 (2017).","journal-title":"Front. Immunol."},{"key":"16877_CR73","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","volume":"32","author":"N Ritz","year":"2008","unstructured":"Ritz, N., Hanekom, W. A., Robins-Browne, R., Britton, W. J. & Curtis, N. Influence of BCG vaccine strain on the immune response and protection against tuberculosis. FEMS Microbiol. Rev. 32, 821\u2013841 (2008).","journal-title":"FEMS Microbiol. Rev."},{"key":"16877_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski, P. Regulation of immune responses by prostaglandin E2. J. Immunol 188, 21\u201328 (2012).","journal-title":"J. Immunol"},{"key":"16877_CR75","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99\u2013103 (2014).","journal-title":"Nature"},{"key":"16877_CR76","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/ni.1758","volume":"10","author":"M Divangahi","year":"2009","unstructured":"Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899\u2013906 (2009).","journal-title":"Nat. Immunol."},{"key":"16877_CR77","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1093\/infdis\/jis609","volume":"206","author":"V Kaul","year":"2012","unstructured":"Kaul, V. et al. An important role of prostanoid receptor EP2 in host resistance to Mycobacterium tuberculosis infection in mice. J. Infect. Dis. 206, 1816\u20131825 (2012).","journal-title":"J. Infect. Dis."},{"key":"16877_CR78","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1365-2567.2002.01403.x","volume":"106","author":"J Rangel Moreno","year":"2002","unstructured":"Rangel Moreno, J. et al. The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis. Immunology 106, 257\u2013266 (2002).","journal-title":"Immunology"},{"key":"16877_CR79","doi-asserted-by":"publisher","unstructured":"Mai, N. T. et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. eLife 7, https:\/\/doi.org\/10.7554\/eLife.33478 (2018).","DOI":"10.7554\/eLife.33478"},{"issue":"Suppl 3","key":"16877_CR80","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford, L. J. Use of NSAIDs in treating patients with arthritis. Arthritis Res. Ther. 15(Suppl 3), S2\u2013S2 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"16877_CR81","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1086\/444545","volume":"192","author":"K Dheda","year":"2005","unstructured":"Dheda, K. et al. Lung remodeling in pulmonary tuberculosis. J. Infect. Dis. 192, 1201\u20131209 (2005).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16877-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16877-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T18:23:11Z","timestamp":1670264591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-16877-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,16]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["16877"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-16877-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/521609","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,16]]},"assertion":[{"value":"1 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3062"}}